The Invesco Perpetual UK Aggressive Fund aims to achieve long term capital growth through a portfolio of primarily UK securities. Investment may occasionally be made in securities of companies with significant sources of profit from, or close economic links with, the UK. The fund will normally hold a concentrated portfolio of stocks and there will be no direct correlation to any specific index.
Name | % Net Assets |
---|---|
Vodafone | 7.5% |
GlaxoSmithKline | 7.0% |
AstraZeneca | 5.6% |
Imperial Tobacco | 5.3% |
National Grid | 5.2% |
BG | 5.1% |
BP | 4.9% |
British American Tobacco | 4.9% |
Koninklijke KPN | 4.6% |
Provident Financial | 4.4% |
Key | % Net Assets |
---|---|
Vodafone | 7.5% |
GlaxoSmithKline | 7.0% |
AstraZeneca | 5.6% |
Imperial Tobacco | 5.3% |
Other | 74.6% |
Date | 18-Sep-2020 |
---|---|
NAV | 206.21p |
Currency | GBP |
Change | -0.31p |
% | -0.15% |
YTD change | 206.21p |
YTD % | n/a |
Fund Inception | 02/07/2001 |
---|---|
Fund Manager | Ed Burke |
TER | 1.70 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.26% |
Annual Mang't | 1.67% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.05 |
You are here: research